Skip to main content
Type at least 3 characters

43,335 articles

Original Research

Accepted on 10 Apr 2025

Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines

in Cancer Immunity and Immunotherapy

  • Cynthia González Muñoz
  • Rydell Alvarez Arzola
  • Adanays Calvo PĂ©rez
  • Milagro de la Caridad FrĂłmeta CampanĂłn
  • Patricia Hernández Casaña
  • AymĂ© Fernández-Calienes ValdĂ©s
  • Patricia Lorenzo-Luaces
  • Zaima Mazorra Herrera
  • Tania Crombet Ramos
  • Mayrel Labrada Mon
Frontiers in Immunology
doi 10.3389/fimmu.2025.1585597